Evidence map›Paper›PMID 32518175›Full record

ArticleJournal of medical genetics2021

Genetic and functional insights into CDA-I prevalence and pathogenesis.

Aude-Anais Olijnik, Noémi B A Roy, Caroline Scott, Joseph A Marsh, Jill Brown, Karin Lauschke, Katrine Ask, Nigel Roberts, Damien J Downes, Sanja Brolih and 19 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of medical genetics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Mechanism of ASF1 engagement by CDAN1.Nature communications · 2025
    Article
  8. Article
  9. Hereditary disorders of ineffective erythropoiesis.Blood cells, molecules & diseases · 2025
    Review
  10. Mechanism of ASF1 Inhibition by CDAN1.bioRxiv : the preprint server for biology · 2024
    Article
  11. Review
  12. Article
  13. Frontiers in physiology · 2021
    Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors at 11 institutions in 9 countries.

Aude-Anais Olijnik *MRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.
Noémi B A Roy *MRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.
Caroline ScottMRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.
Joseph A MarshMRC Human Genetics Unit, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, UK.
Jill BrownMRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.
Karin LauschkeBiotech Research and Innovation Centre (BRIC), Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark.ORCID 0000-0001-8016-7190
Katrine AskBiotech Research and Innovation Centre (BRIC), Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark.
Nigel RobertsMRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.ORCID 0000-0002-5091-3604
Damien J DownesMRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.
Sanja BrolihDepartment of Oncology, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.
Errin JohnsonSir William Dunn School of Pathology, University of Oxford, Oxford, UK.
Barbara XellaMRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.
Melanie ProvenMolecular Haematology Laboratory, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Ria HipkissMolecular Haematology Laboratory, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Kate RyanHaematology Department, Manchester University NHS Foundation Trust, Manchester, UK.
Per FriskDepartment of Women's and Children's Health, Uppsala University and Uppsala University Childrens' Hospital, Uppsala, Sweden.
Johan MäkkCentre for Health Development, Västmanland Region, Uppsala University, Uppsala, Sweden.
Eva-Lena Maria StattinDepartment of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
Nandini SadasivamHaematology Department, Manchester University NHS Foundation Trust, Manchester, UK.
Louisa McIlwaineDepartment of Haematology, NHS Trust Greater Glasgow and Clyde, Glasgow, UK.
Quentin A HillDepartment of Haematology, St James's University Hospital, Leeds, UK.
Raffaele RenellaPediatric Hematology-Oncology Laboratory, Lausanne University Hospital and University of Lausanne, Lausanne, VD, Switzerland.
Jim R HughesMRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.
Richard J GibbonsMRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.
Anja GrothBiotech Research and Innovation Centre (BRIC), Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark.
Peter J McHughDepartment of Oncology, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.
Douglas R HiggsMRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.
Veronica J BuckleMRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.
Christian BabbsMRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK christian.babbs@imm.ox.ac.uk.ORCID 0000-0002-1898-5878
University of Oxford · GBUniversity of Copenhagen · DKManchester University NHS Foundation Trust · GBOxford University Hospitals NHS Trust · GBUppsala University · SEInstitute of Genetics and Cancer · GBJohn Radcliffe Hospital · GBNHS Greater Glasgow and Clyde · GBSt James's University Hospital · GBUniversity of Lausanne · CHUppsala University Hospital · SE

Funding

Medical Research Council MC_UU_00016/1Medical Research Council MC_UU_00016/14Medical Research Council MC_UU_00016/3Medical Research Council MC_UU_12009/1Medical Research Council MC_UU_12009/15Medical Research Council MR/M02122X/1Wellcome Trust 106130Wellcome Trust 106130/Z/14/Z
6 · The paper itself

Abstract

backgroundCongenital dyserythropoietic anaemia type I (CDA-I) is a hereditary anaemia caused by biallelic mutations in the widely expressed genes

methodsGenetic analysis of a cohort of patients with CDA-I identifies novel pathogenic variants in both known causative genes. We analyse the mutation distribution and the predicted structural positioning of amino acids affected in Codanin-1, the protein encoded by

resultsWe identify six novel

conclusionStability and interaction data suggest that C15orf41 may be the key determinant of CDA-I and offer insight into the mechanism underlying this disease. Both proteins share a common pathway likely to be present in a wide variety of cell types; however, nucleolar enrichment may provide a clue as to the erythroid specific nature of CDA-I. The surprisingly high predicted incidence of CDA-I suggests that better ascertainment would lead to improved patient care.

Indexed as

Genetic Predisposition to DiseaseAnemia, Dyserythropoietic, CongenitalFemaleGene Expression RegulationGenetics, PopulationGenetic TestingGlycoproteinsHumansMaleMultiprotein ComplexesMutationNuclear ProteinsTranscription FactorsCDAN1 protein, humanGlycoproteinsMultiprotein ComplexesNuclear ProteinsTranscription Factorscell biologyclinical geneticshaematology (incl Blood transfusion)molecular genetics

Identifiers

PMID32518175
PMCPMC7613268
OpenAlexW3032857606

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.